Justia Intellectual Property Opinion Summaries
ORACLE INTERNATIONAL CORPORATION V. RIMINI STREET, INC.
Oracle International Corporation sued Rimini Street, Inc. for copyright infringement and violations of the Lanham Act. Oracle alleged that Rimini, a third-party provider of software support services, infringed on its copyrights by using Oracle's software in unauthorized ways. Rimini had previously been found to infringe Oracle's copyrights and had changed its business model, seeking a declaratory judgment that its new processes did not infringe Oracle's copyrights. Oracle counterclaimed, leading to a bench trial.The United States District Court for the District of Nevada found that Rimini's new processes still infringed Oracle's copyrights and issued a permanent injunction against Rimini. The court ordered Rimini to delete various software files and issue a press release correcting alleged misstatements. Rimini appealed the decision, challenging several aspects of the district court's rulings.The United States Court of Appeals for the Ninth Circuit reviewed the case and vacated the district court's holding that Rimini created infringing derivative works based solely on interoperability with Oracle's programs. The court explained that a derivative work must incorporate Oracle's copyrighted work, either literally or nonliterally. The court also vacated the district court's ruling striking Rimini's affirmative defense under 17 U.S.C. § 117(a), which allows the owner of a copy of a computer program to make another copy for certain purposes.Additionally, the Ninth Circuit vacated the district court's ruling that Rimini's creation of "gap customer" environments and use of automated tools to deliver PeopleSoft updates constituted copyright infringement. The court also reversed the district court's ruling that Rimini's security-related statements, except for one about "holistic security," constituted false advertising under the Lanham Act. The court vacated the portions of the injunction appealed by Rimini and remanded the case for further proceedings consistent with its opinion. View "ORACLE INTERNATIONAL CORPORATION V. RIMINI STREET, INC." on Justia Law
PALO ALTO NETWORKS, INC. v. CENTRIPETAL NETWORKS, LLC
Palo Alto Networks, Inc. (PAN) petitioned for inter partes review (IPR) of claims 1–18 of Centripetal Networks, LLC’s U.S. Patent No. 10,530,903, asserting that the claims were unpatentable for obviousness based on three prior-art references. The United States Patent and Trademark Office Patent Trial and Appeal Board (the Board) concluded that PAN had not established by a preponderance of the evidence that the claims would have been obvious over the relevant prior art combination.The Board found that PAN’s argument regarding the motivation to combine the references was not sufficiently articulated in the petition. Specifically, the Board determined that PAN had not provided sufficient evidence to show that a person of ordinary skill in the art would have been motivated to modify Paxton’s computing system to include Sutton’s step of transmitting a notification of malicious activity after Paxton’s correlation step. The Board concluded that PAN had not established that the claims would have been obvious.The United States Court of Appeals for the Federal Circuit reviewed the case and found that the Board erred by failing to clearly explain its holding or rationale regarding the motivation to combine and whether the proposed combination teaches the final limitation of claim 1. The court noted that the Board did not make a clear finding on whether a person of ordinary skill in the art would have been motivated to modify Paxton by adding Sutton’s step of transmitting a notification of malicious activity after Paxton’s correlation step. The court vacated the Board’s decision and remanded the case for further proceedings to clarify and explain its holding on the motivation to combine the references. View "PALO ALTO NETWORKS, INC. v. CENTRIPETAL NETWORKS, LLC " on Justia Law
Crown Packaging Technology, Inc. v. Belvac Production Machinery, Inc.
Crown Packaging Technology, Inc. and CarnaudMetalbox Engineering Ltd. (collectively, “Crown”) sued Belvac Production Machinery, Inc. (“Belvac”) for infringing claims of U.S. Patent Nos. 9,308,570, 9,968,982, and 10,751,784, which relate to necking machines used in manufacturing metal beverage cans. Belvac argued that the patents were invalid under pre-AIA 35 U.S.C. § 102(b) because a necking machine embodying the invention was on sale in the U.S. before the critical date. Both parties sought summary judgment on this issue.The United States District Court for the Western District of Virginia granted summary judgment to Crown, ruling that the patents were not invalid under the on-sale bar, and denied Belvac’s motion. After a jury trial, the court entered a judgment that the asserted claims were not invalid and not infringed. Crown appealed the noninfringement judgment, and Belvac appealed the no invalidity judgment.The United States Court of Appeals for the Federal Circuit reviewed the case. The court held that the letter sent by Crown to Complete Packaging Machinery constituted a commercial offer for sale in the U.S. before the critical date, thus invalidating the patents under § 102(b). The court reversed the district court’s summary judgment in favor of Crown and remanded for entry of judgment in Belvac’s favor. The court did not address the issue of infringement due to the invalidity finding. View "Crown Packaging Technology, Inc. v. Belvac Production Machinery, Inc." on Justia Law
Phoenix Lighting Group, L.L.C. v. Genlyte Thomas Group, L.L.C.
Phoenix Lighting Group, L.L.C. (Phoenix) sued Genlyte Thomas Group, L.L.C. (DCO) and obtained a jury verdict for tortious interference, misappropriation of trade secrets, and civil conspiracy. The jury awarded Phoenix compensatory and punitive damages, as well as reasonable attorney fees. The trial court awarded additional punitive damages for the misappropriation claim and enhanced the attorney fees by a multiplier of two.The Ninth District Court of Appeals affirmed the trial court's decision in part but reversed the application of the punitive-damages cap for the conspiracy claim, remanding the case for further proceedings. Phoenix requested postjudgment attorney fees, which the Ninth District did not specifically address but remanded the case for further proceedings consistent with its opinion.The Supreme Court of Ohio accepted jurisdiction over DCO's challenge to the enhancement of the attorney-fee award. The court reversed the Ninth District's affirmation of the enhanced attorney fees and remanded the case to the trial court to issue a final judgment granting Phoenix attorney fees in the amount of $1,991,507.On remand, the trial court awarded Phoenix postjudgment attorney fees and expenses. The Ninth District affirmed this award, concluding that the trial court had jurisdiction to consider postjudgment attorney fees and did not exceed its authority.The Supreme Court of Ohio reviewed the case and held that the trial court exceeded its authority by considering and granting Phoenix's motion for postjudgment attorney fees and expenses. The court reversed the Ninth District's judgment and remanded the case to the trial court with instructions to vacate its award of postjudgment attorney fees and expenses and to enter final judgment. View "Phoenix Lighting Group, L.L.C. v. Genlyte Thomas Group, L.L.C." on Justia Law
DDR Holdings, LLC v. Priceline.com LLC
DDR Holdings, LLC (DDR) sued Priceline.com LLC and Booking.com B.V. (collectively, Priceline.com) for infringement of U.S. Patent No. 7,818,399 (’399 patent). The ’399 patent relates to generating a composite web page that combines visual elements of a “host” website with content from a third-party “merchant.” The dispute centered on the construction of the claim terms “merchants” and “commerce object.” DDR argued that “merchants” should include purveyors of both goods and services, while Priceline.com contended it should be limited to purveyors of goods alone.The United States District Court for the District of Delaware construed “merchants” as “producers, distributors, or resellers of the goods to be sold” and “commerce object” to exclude services. Following this construction, the parties stipulated to non-infringement, agreeing that the accused instrumentalities did not infringe the asserted claims of the ’399 patent under the court’s claim constructions. The district court entered final judgment in favor of Priceline.com, and DDR appealed.The United States Court of Appeals for the Federal Circuit reviewed the district court’s claim construction de novo. The court affirmed the district court’s construction of “merchants” as purveyors of goods, not services, noting the significant deletion of any reference to services in the final specification of the ’399 patent compared to the provisional application. The court also affirmed the construction of “commerce object” as “a product, a product category, a catalog, or an indication that a product, product category, or catalog should be chosen dynamically,” consistent with the construction of “merchants.”The Federal Circuit concluded that the district court correctly construed the disputed terms and affirmed the judgment of non-infringement in favor of Priceline.com. View "DDR Holdings, LLC v. Priceline.com LLC" on Justia Law
Galderma Laboratories, L.P. v. Lupin, Inc.
Galderma Laboratories, L.P. and TCD Royalty Sub LP (collectively, Galderma) own and market Oracea®, a doxycycline-based treatment for rosacea. They hold U.S. Patent Nos. 7,749,532 and 8,206,740 (the Asserted Patents), which cover a specific formulation of doxycycline. Lupin Inc. and Lupin Ltd. (collectively, Lupin) filed an abbreviated new drug application (ANDA) to market a generic version of Oracea®, claiming bioequivalence. Galderma sued Lupin for patent infringement under the Hatch-Waxman Act, asserting that Lupin’s product infringed the Asserted Patents.The United States District Court for the District of Delaware held a three-day bench trial and found that Lupin’s ANDA product did not infringe the Asserted Patents. The court concluded that Galderma failed to prove that Lupin’s product met the specific formulation requirements of the Asserted Patents, particularly the immediate release (IR) and delayed release (DR) portions of doxycycline. The court also found that Galderma did not demonstrate infringement under the doctrine of equivalents.The United States Court of Appeals for the Federal Circuit reviewed the case. Galderma argued that the district court erred in disregarding dissolution test data from Lupin’s ANDA, admitting evidence from a rebuttal batch, imposing additional claim limitations, and not finding infringement under the doctrine of equivalents. The Federal Circuit found no clear error in the district court’s findings. It held that the district court correctly determined that the two-stage dissolution test did not represent in vivo behavior and that Galderma did not prove its theory of infringement. The court also found no abuse of discretion in admitting the rebuttal batch evidence and no imposition of additional claim limitations. Finally, the court upheld the district court’s finding that Galderma did not prove infringement under the doctrine of equivalents.The Federal Circuit affirmed the district court’s decision, concluding that Lupin’s ANDA product did not infringe the Asserted Patents. View "Galderma Laboratories, L.P. v. Lupin, Inc." on Justia Law
PS Products, Inc. v. Panther Trading Co., Inc.
PS Products, Inc. and Billy Pennington (collectively, PSP) own a U.S. Design Patent for a long-spiked electrode for a stun device. They filed a lawsuit in the Eastern District of Arkansas against Panther Trading Company, Inc. (Panther) for patent infringement. Panther responded with a Rule 11 letter and a motion to dismiss, arguing the infringement claims were frivolous and the venue was improper. PSP did not respond to these communications and later moved to voluntarily dismiss the case with prejudice. Panther then sought attorney fees and sanctions, claiming the lawsuit was frivolous.The United States District Court for the Eastern District of Arkansas dismissed the case with prejudice and awarded Panther attorney fees and costs under 35 U.S.C. § 285, deeming the case exceptional. The court also imposed $25,000 in deterrence sanctions on PSP under its inherent power, citing PSP's history of filing meritless lawsuits. PSP filed a motion for reconsideration of the sanctions, which the district court denied.The United States Court of Appeals for the Federal Circuit reviewed the case. PSP appealed the $25,000 sanctions, arguing the district court lacked authority to impose them in addition to attorney fees and that the court applied the wrong legal standard. The Federal Circuit held that the district court did not err in imposing sanctions under its inherent power, even after awarding attorney fees under § 285. The court found that PSP's conduct, including filing a meritless lawsuit and citing the wrong venue statute, justified the sanctions. The Federal Circuit affirmed the district court's decision and declined Panther's request for attorney fees for the appeal, determining the appeal was not frivolous as argued. View "PS Products, Inc. v. Panther Trading Co., Inc." on Justia Law
MIRROR WORLDS TECHNOLOGIES, LLC v. META PLATFORMS, INC.
Mirror Worlds Technologies, LLC owns three patents related to methods for storing, organizing, and presenting data in time-ordered streams on a computer system. In 2017, Mirror Worlds sued Meta Platforms, Inc. (formerly Facebook, Inc.) for patent infringement, alleging that Facebook's features, such as News Feed, Timeline, and Activity Log, infringed on these patents. Facebook moved for summary judgment of non-infringement, which the district court granted, concluding that Facebook did not infringe the patents as a matter of law.The United States District Court for the Southern District of New York found that Facebook's systems did not meet the "main stream" or "main collection" limitations of the patents, as the evidence showed that not all data units received or generated by Facebook's systems were stored in the accused main streams. The court also rejected Facebook's defense of invalidity under 35 U.S.C. § 101 but granted summary judgment of non-infringement on several grounds, including that the accused systems did not display a "glance view" as required by the '538 and '439 patents.The United States Court of Appeals for the Federal Circuit reviewed the case and affirmed the district court's summary judgment of non-infringement. The Federal Circuit agreed with the district court's construction of "data unit" and found that the evidence supported the conclusion that Facebook's systems received data units not stored in the accused main streams. The court also upheld the exclusion of certain evidence presented by Mirror Worlds and found no genuine dispute of material fact regarding the "glance view" limitation. Consequently, the Federal Circuit affirmed the judgment of non-infringement and dismissed Facebook's cross-appeal regarding the invalidity defense. View "MIRROR WORLDS TECHNOLOGIES, LLC v. META PLATFORMS, INC. " on Justia Law
CYTIVA BIOPROCESS R&D AB v. JSR CORP.
Cytiva BioProcess R&D AB ("Cytiva") appealed the final written decisions from six inter partes reviews (IPRs) that determined 79 claims of three challenged patents were unpatentable. JSR Corp. and JSR Life Sciences, LLC (collectively, "JSR") cross-appealed the decisions in four of these IPRs, which held the remaining four challenged claims not unpatentable. The patents in question relate to chromatography matrices and processes for isolating target compounds using those matrices, specifically involving a ligand made from Protein A (SPA) found in staphylococcus aureus.The Patent Trial and Appeal Board (Board) found that it would have been obvious to make the G29A mutation to Domain C of SPA based on prior art, which suggested this modification for any of the SPA domains. The Board held that claims 1–7, 10–20, 23–26 of the '765 patent, claims 1–3, 5–7, 10–16, 18–20, 23–30 of the '142 patent, and claims 1–10, 12–14, 16–28, 30–32, and 34–37 of the '007 patent were unpatentable. However, the Board found that claims 4 and 17 of the '142 patent and claims 11 and 29 of the '007 patent were not unpatentable, as JSR had not shown a reasonable expectation of success for these claims.The United States Court of Appeals for the Federal Circuit affirmed the Board's determination that the majority of the claims were unpatentable, agreeing that the prior art expressly suggested the G29A modification to Domain C. The court also concluded that the Board erred in limiting the construction of "Fab part of an antibody" to Fab fragments and reversed the Board's determination that claims 4 and 17 of the '142 patent and claims 11 and 29 of the '007 patent were not unpatentable. The court held that if a property of a composition is inherent, there is no question of a reasonable expectation of success in achieving it, and thus, both the composition and process claims were unpatentable. View "CYTIVA BIOPROCESS R&D AB v. JSR CORP." on Justia Law
US Ghost Adventures, LLC v. Miss Lizzie’s Coffee LLC
US Ghost Adventures, LLC (Ghost Adventures) operates a bed and breakfast at the Lizzie Borden House in Fall River, Massachusetts, offering ghost tours and related activities. Ghost Adventures holds federal trademarks for the name "Lizzie Borden" and a hatchet logo. Miss Lizzie's Coffee LLC (Miss Lizzie's) opened a coffee shop next to the Lizzie Borden House, using the Lizzie Borden story in its marketing, including a hatchet logo and references to being "The Most Haunted Coffee Shop in the World." Some visitors mistakenly believed the two businesses were affiliated.Ghost Adventures sued Miss Lizzie's in the United States District Court for the District of Massachusetts for trademark infringement and unfair competition, seeking a preliminary injunction to stop Miss Lizzie's from using the "Lizzie Borden" name and hatchet logo. The district court denied the preliminary injunction, finding that Ghost Adventures failed to show a likelihood of success on the merits. The court determined that the key element in any infringement action is the likelihood of confusion, which Ghost Adventures did not demonstrate. The court found that Miss Lizzie's hatchet logo and use of the name "Lizzie" were not similar enough to Ghost Adventures' trademarks to cause confusion.The United States Court of Appeals for the First Circuit reviewed the case and affirmed the district court's decision. The appellate court agreed that the district court did not clearly err in finding that the hatchet logos were dissimilar and that Miss Lizzie's reference to "Lizzie" was to the historical figure, not the trademark. The court also found that any consumer confusion was due to the proximity of the businesses and their common reliance on the Lizzie Borden story, not the similarity of their marks. The court concluded that Ghost Adventures did not demonstrate a likelihood of success on the merits, and the district court's denial of the preliminary injunction was affirmed. View "US Ghost Adventures, LLC v. Miss Lizzie's Coffee LLC" on Justia Law